![Ethyl-4-hydroxy-7-methyl-2-oxo-1-(prop-2-ynyl)-1,2-dihydro-1,8-naphthyridine-3-carboxylate ≥95% | VWR Ethyl-4-hydroxy-7-methyl-2-oxo-1-(prop-2-ynyl)-1,2-dihydro-1,8-naphthyridine-3-carboxylate ≥95% | VWR](https://us.vwr.com/stibo/bigweb/std.lang.all/75/53/9197553.jpg)
Ethyl-4-hydroxy-7-methyl-2-oxo-1-(prop-2-ynyl)-1,2-dihydro-1,8-naphthyridine-3-carboxylate ≥95% | VWR
![Discovery of Novel 7-Hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide Derivatives with Potent and Selective Antifungal Activity against Cryptococcus Species | Journal of Medicinal Chemistry Discovery of Novel 7-Hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide Derivatives with Potent and Selective Antifungal Activity against Cryptococcus Species | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c00794/asset/images/large/jm2c00794_0012.jpeg)
Discovery of Novel 7-Hydroxy-5-oxo-4,5-dihydrothieno[3,2-b]pyridine-6-carboxamide Derivatives with Potent and Selective Antifungal Activity against Cryptococcus Species | Journal of Medicinal Chemistry
![OXO Announces New Nonprofit Partners as Part of its 1% for the Planet Giving Commitment - NS Healthcare OXO Announces New Nonprofit Partners as Part of its 1% for the Planet Giving Commitment - NS Healthcare](https://www.ns-healthcare.com/wp-content/uploads/sites/13/2023/02/1ftp_BusinessMember_Horizontal_FullColor_Logo-scaled.jpg)